Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Fragment Based Lead Discovery

Iwan De Esch's Biography

Iwan De Esch, Associate Professor, VU University Amsterdam

Dr Iwan de Esch did his PhD research at the Department of Pharmacochemistry, VU University Amsterdam, The Netherlands. In 1998, he became research associate at the Drug Design Group of the University of Cambridge. Dr de Esch is a co-founder of De Novo Pharmaceuticals (2000) where he worked as a group and project leader. Dr de Esch returned to academia in 2003 and is now associate professor at the Medicinal Chemistry Department. The group focuses on two research lines, namely G-protein-coupled receptors (GPCRs) and fragment-based drug design (FBDD). Dr. de Esch is also co-founder of IOTA Pharmaceuticals Ltd (2007) and Griffin Discoveries BV (2009). In 2011, he was awarded the Galenus Research Price for his work on FBDD.

Iwan De Esch Image

Fragment-Based Approaches Applied to G Protein-Coupled Receptors (GPCRs)

Tuesday, 13 March 2012 at 11:45

Add to Calendar ▼2012-03-13 11:45:002012-03-13 12:45:00Europe/LondonFragment-Based Approaches Applied to G Protein-Coupled Receptors (GPCRs)

In recent years, highly innovative fragment-based drug discovery technologies and approaches have been developed for a variety of drug target classes and these can now be used to study ligand-GPCR interaction.

Add to Calendar ▼2012-03-13 00:00:002012-03-14 00:00:00Europe/LondonFragment Based Lead